amsonic acid: Clinical Trials

5 trials of amsonic acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting, 1 withdrawn. 3 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow amsonic acid: new trials by email Literature Review of amsonic acid trials Research Report on amsonic acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Surgical Techniques for Anterior Shoulder Instability
Arthroscopic Dynamic Anterior Stabilization, Arthroscopic Bankart Repair - Surgeons, Shoulder Instability
Not applicableRecruitingRiga Stradins University602024-11-012026-10-15
Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS
BP1001 (varying dose), BP1001 (fixed dose), Dasatinib - Chronic Myelogenous Leukemia, Ph1-Positive, Acute Myeloid Leukemia
Phase 1 / Phase 2WithdrawnBio-Path Holdings, Inc.2017-09-012020-05-28
The Dads in Gear Program: An Innovative Men-centered Approach to Smoking Cessation
Dads in Gear Program - Smoking Cessation
Not applicableCompletedUniversity of British Columbia362014-08-012018-07-16
Feasibility and Acceptability of Culturally Adapted Group Psychosocial Intervention for Depressed Fathers
LTP Plus Dads - Depression
Not applicableCompletedPakistan Institute of Living and Learning182009-08-012020-12-11
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
Differential Abilities Scale, Neuropsychological Testing - Epilepsy, Seizure
CompletedEmory University3312000-09-012013-11-11

Conditions studied

Bankart Lesions (1)  ·  Behavior (1)  ·  Cognition Disorders (1)  ·  Depression (1)  ·  Epilepsy (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Masculinity (1)  ·  Myelodysplastic Syndromes (1)  ·  Seizures (1)  ·  Smoking Cessation (1)

Sponsors

Bio-Path Holdings, Inc. (1)  ·  Emory University (1)  ·  Pakistan Institute of Living and Learning (1)  ·  Riga Stradins University (1)  ·  University of British Columbia (1)

Countries

United States (2)  ·  Latvia (1)  ·  United Kingdom (1)

Top investigators

Joan Bottorff, PhD (1)  ·  John Oliffe, PhD (1)  ·  Kimford J. Meador, M.D. (1)  ·  Maro Ohanian, M.D. (1)

Results publications

PMID 16894099, PMID 23352199, PMID 24934501, PMID 31871217, PMID 33419080

NIH funding

R01NS038455 (1)